You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate-1-risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

Not yet recruiting
  • MDS
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2021

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
Jan 12, 2022

Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022

Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1, EBV-DNA=4000 Copy/ml Trial in Guangzhou (Toripalimab, IMRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Yanqun Xiang
Feb 7, 2022

Prostate Cancer Trial in Greenfield Park (HDR brachytherapy as monotherapy)

Completed
  • Prostate Cancer
  • HDR brachytherapy as monotherapy
  • Greenfield Park, Quebec, Canada
    Hôpital Charles LeMoyne
Mar 15, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Cardiology, Coronary Artery Disease Trial (Coronary CT in 1st line compared to the strategy with functional test in 1st line in

Not yet recruiting
  • Cardiology
  • Coronary Artery Disease
  • Coronary CT in 1st line compared to the strategy with functional test in 1st line in patient at Intermediate Risk of Developing Stable Coronary Disease:
  • (no location specified)
May 5, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)

Recruiting
  • Prostate Cancer
  • Low dose rate prostate brachytherapy
  • High Dose Rate prostate brachytherapy
  • Kelowna, British Columbia, Canada
    British Columbia Cancer Agency Center for the Southern Interior
Mar 3, 2022

Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Nov 4, 2022

Anemia Trial in Dresden (ACE-536)

Completed
  • Anemia
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

Metastatic Renal Cell Carcinoma, Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score Trial in France

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
  • Combination PD-1/PD-L1 ICI + VEGFR-TKI
  • Treatment pause
  • Bayonne, France
  • +24 more
Aug 10, 2022

MDS Trial in Dresden (ACE-536)

Completed
  • Myelodysplastic Syndromes
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

MDS Trial in Bronx (Pyrimethamine)

Withdrawn
  • Myelodysplastic Syndromes
  • Bronx, New York
    Montefiore Medical Center
Sep 15, 2021

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Nivolumab, Cisplatin, Cetuximab)

Completed
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Palo Alto, California
  • +10 more
Nov 22, 2022

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020

Myelodysplastic Syndrome (MDS) Trial in United States (AMV564 14-Day CIV)

Completed
  • Myelodysplastic Syndrome (MDS)
  • AMV564 14-Day CIV
  • Duarte, California
  • +4 more
Oct 11, 2021

MDS Trial in France, Germany (N-Plate / romiplostim)

Completed
  • Myelodysplastic Syndromes
  • N-Plate / romiplostim
  • Annecy, France
  • +35 more
Sep 7, 2021

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023